Investigation of the hypothalamic regulation of food intake, energy expenditure and body adiposity by neuropeptides

Lead Research Organisation: ICSTM at Hammersmith
Department Name: Medicine


Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.


10 25 50

publication icon
Turner JJ (2009) Induction of TLR tolerance in human macrophages by adiponectin: does LPS play a role? in Scandinavian journal of immunology

publication icon
Troke RC (2014) The future role of gut hormones in the treatment of obesity. in Therapeutic advances in chronic disease

publication icon
Thompson EL (2010) Modulation of the hypothalamic-pituitary-gonadal axis by selective ligands of the KISS1R. in Current opinion in investigational drugs (London, England : 2000)

publication icon
Tharakan G (2011) Emerging therapies in the treatment of 'diabesity': beyond GLP-1. in Trends in pharmacological sciences

Company Name Thiakis 
Description Thiakis Ltd., an Imperial College spin out company was formed in 2004 to develop findings from Professor Bloom's laboratory into treatments for obesity and associated conditions. ; Acquired by Pfizer in 2008 
Year Established 2004 
Impact Thiakis raised £10 million funding in 2006, and was sold to Wyeth for £20 million followed by additional potential milestones payments totalling up to £80 million, in December 2008.
Description Knighthood honour for 'outstanding' obesity expert 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact

Publicity regarding laboratory's work.
Year(s) Of Engagement Activity 2012